IP
You are brave IP.
I wish you well .
I am interested to hear how you have calculated the expected EBIT numbers over the next few years at Geelong
The reference the company made to an ebit of $8.6m at full capacity seems to be the "bible" of seeing what the profit is going to be .
I just cant see how it is going to be more than $4m net
The world leader in this space is a company called Abengoa .
Their division in this area is a buisness called Befesa that in 2009 had $700m of revenue , but only made $40m profit ie 8% of revenue .
From the Befesa annual report
Sales 721.8 -17.4 873.4 169.7 15.6
EBITDA 118.7 -24.8 157.8 34.7 13.1
Net Profit 40.9 -30.3 58.7 14.5 10.9
I am not cetain of the structure but on the surface it .
appears to me Befesa was bought by Abengoa in 2010 , trying to find what the value was
- Forums
- ASX - By Stock
- VYS
- research & resulting questions
research & resulting questions, page-37
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VYS (ASX) to my watchlist
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $131.8M |
Open | High | Low | Value | Volume |
32.0¢ | 32.0¢ | 31.5¢ | $13.83K | 43.42K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9438 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9438 | 0.315 |
6 | 199770 | 0.310 |
2 | 13114 | 0.305 |
3 | 62275 | 0.300 |
2 | 107389 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 30000 | 1 |
0.325 | 48739 | 1 |
0.330 | 100000 | 1 |
0.335 | 13548 | 1 |
0.340 | 122239 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
VYS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online